Genomenon Completes $5.3 Million Financing Round
ANN-ARBOR—Genomenon, the genetics informatics company, has completed a $5.3 million financing round, company officials announced. The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. New investors in this round of financing included BroadOak Capital Partners LLC of Bethesda, Md., Green Park & Golf